异基因造血干细胞移植对镰状细胞病相关器官并发症的影响:系统综述与Meta分析
该系统综述与Meta分析检索MEDLINE/PubMed和EMBASE至2023年9月21日,共纳入34项研究,其中17项(774例患者)进入Meta分析。结果显示肺功能保持稳定,儿童估算肾小球滤过率下降且蛋白尿增加,脾脏摄取和吞噬功能改善,脑血流改善且移植后卒中发生率低。
要点
- 异基因造血干细胞移植可改善部分镰状细胞病相关器官功能障碍,但移植相关毒性可能对其他器官产生不良影响。
- 儿童患者移植后估算肾小球滤过率下降(SMD -0.80,p=0.01),蛋白尿增加(RR 2.00,p<0.01)。
- 脾脏摄取和吞噬功能改善(RR分别为0.31和0.23,p均<0.01),脑血流改善(SMD -1.39,p<0.01)。
核心结论
- 异基因造血干细胞移植可改善部分镰状细胞病相关器官功能障碍,但移植相关毒性可能对其他器官产生不良影响。
- 未来研究应聚焦于识别最可能从移植中获益的镰状细胞病患者以及哪些器官损伤在移植后更可能加重。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE/PubMed和EMBASE至2023年9月21日,共筛选823项研究,纳入34项。
- 其中17项研究(774例患者,23.6%为成人,86.3%为HLA全合同胞供者,56.7%采用清髓性预处理方案)进入Meta分析。
主要发现
- 肺功能保持稳定。
- 平均三尖瓣反流射流速度下降但未达统计学显著。
- 儿童患者估算肾小球滤过率下降(SMD -0.80,p=0.01),蛋白尿增加(RR 2.00,p<0.01)。
- 脾脏摄取和吞噬功能改善(RR 0.31,p<0.01;RR 0.23,p<0.01)。
- 脑血流改善(SMD -1.39,p<0.01),高危患者移植后卒中发生率低。
关键数值与推荐
- 连续数据以标准化均数差(SMD)表示,采用加权逆方差随机效应模型合并。
- 二项数据以风险比(RR)表示,采用Mantel-Haenszel随机效应Meta分析。
- 视网膜病变和无血管性骨坏死仅有一项研究调查,显示无显著变化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 视网膜病变和无血管性骨坏死仅有一项研究调查。
- 未来研究应聚焦于识别最可能从移植中获益的镰状细胞病患者以及哪些器官损伤在移植后更可能加重。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sickle cell disease (SCD)-related organ complications are a major cause of morbidity and mortality in patients with SCD. We sought to assess whether hematopoietic stem cell transplantation (HSCT) stabilizes, attenuates, or exacerbates organ decline. We performed a systematic review and meta-analysis of trials investigating organ function before and after HSCT in patients with SCD. We searched MEDLINE/PubMed and EMBASE up to September 21, 2023. Continuous data were expressed as standardized mean difference (SMD) and pooled in a weighted inverse-variance random-effects model; binomial data were expressed as risk ratio (RR) using the Mantel-Haenszel random-effects meta-analyses. Of 823 screened studies, 34 were included in this review. Of these, 17 (774 patients, 23.6% adults, 86.3% HLA-identical sibling donor, 56.7% myeloablative conditioning regimen) were included in the meta-analyses. Pulmonary function remained stable. Mean tricuspid regurgitant jet velocity decreased but did not reach statistical significance. In children, estimated glomerular filtration rate decreased (SMD -0.80, p = .01), and the presence of proteinuria increased (RR 2.00, p = <.01), while splenic uptake and phagocytic function improved (RR 0.31, p = <.01; RR 0.23, p = <.01). Cerebral blood flow improved (SMD -1.39, p = <.01), and a low incidence of stroke after transplantation in high-risk patients was found. Retinopathy and avascular osteonecrosis were investigated in only one study, showing no significant changes. While HSCT can improve some SCD-related organ dysfunctions, transplantation-related toxicity may have an adverse effect on others. Future research should focus on identifying individuals with SCD who might benefit most from HSCT and which forms of organ damage are more likely to exacerbate post-transplantation.
引用
- Dovern E, Aydin M, DeBaun MR, et al. Effect of allogeneic hematopoietic stem cell transplantation on sickle cell disease-related organ complications: A systematic review and meta-analysis. Am J Hematol. 2024. PMID: 38517255. doi:10.1002/ajh.27297
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。